返回列表Company

[生物健康初创支持平台——培育企业价值1万亿韩元的独角兽企业]

2022-11-28

[Operating Bio/Health 初创企业 Support Platform… Nurturing 'Unicorn Companies' with Valuation of KRW 1 Trillion]

新韩金融集团
Open innovation underway with Celltrion
Contributing to technology improvement and product commercialization… Networking event held in 新加坡
Providing a venue for technology partnership with local companies, creating dedicated fund for continued follow-on investment

Shinhan Financial is also actively supporting the 全球拓展 and 投资引进 of bio/health 初创企业s through 新韩Square Bridge. In September of this year, Shinhan Financial attended the 'RESI Conference,' the world's largest bio conference held in 波士顿, USA. Through this, it provided programs for 全球拓展 including overseas business partner discovery and 投资引进 to 7 bio healthcare 初创企业s.

Among them, 'RudaCure,' a 干眼症治疗药 developer that participated in the RESI Conference, won 3rd place in the Innovator's Pitch Challenge among 60 global participants. RudaCure also earned an opportunity to participate in the 旧金山 投资引进 conference, the largest of its kind in the world.

In particular, given the tight bio/health investment market following the recent economic downturn and interest rate hikes, the plan is to proactively identify K-bio/health 初创企业s and support 投资引进 to enable successful business expansion in both 国内外 markets.

返回列表